Abstract
To identify factors related to poor control of blood pressure in primary care, we designed a retrospective case–control analysis of clinical and demographic data recorded in the General Practitioners (GP) database. Study data were provided on a voluntary basis by 21 GPs from a practice-based network in primary care. The study included 2519 hypertensive patients enrolled between January 1 and December 31, 2000. The interventions were antihypertensive medication, and the main outcome measures were control of systolic and diastolic blood pressure (BP). The independent variables considered were: age of patient and GP; patient gender, body mass index, history of smoking, diabetes mellitus, or cholesterol tests; family history of hypertension; previous visits for cardiologic, nephrologic, or vascular surgery evaluation; prior hospitalizations for myocardial infarction or heart failure, and number of admissions for surgery; length of patient follow-up, type of antihypertensive medication, mean daily dosage, adherence to the drug regimen, and number of other medications currently being taken by the patient. Blood pressure was uncontrolled (>140/90 mmHg) in 1525 (60%) of the 2519 hypertensive patients enrolled. The presence of diabetes mellitus, increasing patient age, and increasing GP age significantly increased the risk of uncontrolled BP. Factors significantly associated with a reduced risk of uncontrolled BP were the number of other medications currently being taken by the patient and a prior history of MI. We conclude that the failure of antihypertensive medication to adequately control BP is determined by both the patient's characteristics and factors related to the patient–doctor relationship. Successful treatment of hypertension requires patient adherence to the regimen that has been agreed on by the patient and the physician.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
ISTAT. Health conditions of the population and recourse to health services, 1999.
Degli Esposti E et al. Progetto ATLAS: modello per una valutazione globale dell'uso dei farmaci antiipertensivi. Mecosan 1999; 31: 93–98.
Sturani A et al. Assessment of antihypertensive drug use in primary care in Ravenna, Italy, based on data collected in the PANDORA Project. Clin Ther 2002; 24: 249–259.
Joint National Committee on Detection, Evaluation Treatment of Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413–2446.
Burt VL et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination survey, 1960 to 1991. Hypertension 1995; 26: 60–69.
Colhoun HM, Dong W, Poulter NR . Blood pressure screening, management and control in England: results from the healthy survey for England 1994. J Hypertens 1998; 16: 747–752.
Marques-Vidal P, Tuomilehto J . Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid? J Hum Hypertens 1997; 11: 213–223.
Degli Esposti E et al. The PANDORA project: results of the pilot study. Am J Hypertens 1999; 12: 790–796.
Armitage P, Betty G Statistica Medica. Mc Graw-Hill libri: Milano, Italia, 1996.
Hosmer D, Lemeshow S Applied Logistic Regression. J Wiley & Sons: New York, 1989.
SPSS Inc. for Windows, version 10.0, Chicago, IL, 1999.
Neaton JD et al. Treatment of mild hypertension study. JAMA 1993; 270: 713–724.
Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for the older patients with isolated hypertension: The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757–764.
Final results of the Systolic Hypertension in the Elderly Program (SHEP). prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255–3264.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703–713.
Pearce KA, Furberg CD, Rushing J . Does antihypertensive treatment of the elderly prevent cardiovascular events or prolong life? A meta-analysis of hypertension treatment trials. Arch Fam Med 1995; 4: 943–950.
Pickering TG . Blood pressure measurement and detection of hypertension. Lancet 1994; 344: 31–35.
Reeves RA . Does this patient have hypertension? How to measure blood pressure. JAMA 1995; 273: 1211–1218.
Hyman DJ, Pavlik VN . Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479–486.
Asay Y, Heller R, Kajii E . Hypertension control and medication increase in primary care. J Hum Hypertens 2002; 16: 313–318.
Knight EL et al. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38: 809–814.
Di Bari M et al. Undertreatment of hypertension in community-dwelling older adults: a drug-utilization study in Dicomano, Italy. J Hypertens 1999; 17: 1633–1640.
Joshi PP, Salkar RG, Heller RF . Determinants of poor blood pressure control in urban hypertensives of central India. J Hum Hypertens 1996; 10: 299–303.
Cuspidi C et al. Blood pressure control in a hypertension hospital clinic. J Hypertens 1999; 17: 835–841.
Williams GH . Hypertensive vascular disease. In: Harrison TR, Fauci AS (eds). Harrison's Principles of Internal Medicine, 14th ed. McGraw-Hill: New York, 1998; p 1382.
Graves JW, Bloomfield RL, Buckalew Jr VM . Plasma volume in resistant hypertension: guide to pathophysiology and therapy. Am J Med Sci 1989; 298: 361–365.
Berlowitz DR et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–1963.
Degli Esposti E et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16: 439–444.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was carried out by CliCon Srl.
Rights and permissions
About this article
Cite this article
Degli Esposti, E., Di Martino, M., Sturani, A. et al. Risk factors for uncontrolled hypertension in Italy. J Hum Hypertens 18, 207–213 (2004). https://doi.org/10.1038/sj.jhh.1001656
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001656
Keywords
This article is cited by
-
Hypertension, uncontrolled hypertension and resistant hypertension: prevalence, comorbidities and prescribed medications in 228,406 adults resident in urban areas. A population-based observational study
Internal and Emergency Medicine (2023)
-
Feasibility and Preliminary Outcomes of a Web and Smartphone–Based Medication Self-Management Platform for Chronically Ill Patients
Journal of Medical Systems (2016)
-
Antihypertensive Medication Initiation Among Young Adults with Regular Primary Care Use
Journal of General Internal Medicine (2014)
-
Prevalence, awareness, treatment and control of hypertension in the Palestinian population
Journal of Human Hypertension (2013)
-
Prevalence, awareness, treatment and control of hypertension in Vietnam—results from a national survey
Journal of Human Hypertension (2012)